Analysis of reticulocyte parameters on the Sysmex XE 5000 and LH 750 analyzers in the diagnosis of inefficient erythropoiesis

International Journal of Laboratory Hematology

Volumn 33, Issue 1, 2011, Pages 37-44

  Urrechaga, E ^a   Borque, L ^b   Escanero, J F ^b  

^a HOSPITAL DE GALDAKAO   (Spain)

^b UNIVERSITY OF ZARAGOZA   (Spain)

Author keywords

Anemia; Erythropoiesis; Red blood cell size factor (RSf); Reticulocyte hemoglobin equivalent (Ret He)

Indexed keywords

GLOBIN; HEMOGLOBIN; IRON;

ANALYZER; ARTICLE; BETA THALASSEMIA; BLOOD DISEASE; CELL SIZE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; HUMAN; INEFFICIENT ERYTHROPOIESIS; IRON DEFICIENCY ANEMIA; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RELIABILITY; RETICULOCYTE;

ANEMIA; ERYTHROCYTE INDICES; HEMATOLOGIC TESTS; HEMOGLOBINS; HUMANS; REPRODUCIBILITY OF RESULTS; RETICULOCYTES; SENSITIVITY AND SPECIFICITY;

EID: 78651095766     PISSN: 17515521     EISSN: 1751553X     Source Type: Journal    
DOI: 10.1111/j.1751-553X.2010.01238.x     Document Type: Article

References (23)

1. Briggs C., Rogers R., Thompson B. & Machin S.J. (2001) New red cell parameters on the Sysmex XE 2100 as potential markers of functional iron deficiency. Infusion Therapy Transfusion Medicine 28, 256-262.
2. Brugnara C. (1998) Use of reticulocyte cellular indices in the diagnosis and treatment of hematological disorders. International Journal of Clinical and Laboratory Research 28, 1-11.
3. Brugnara C. (2000) Reticulocyte cellular indices: a new approach in the diagnosis of anemias and monitoring of erythropoietic function. Critical Reviews in Clinical Laboratory Sciences 37, 93-130.
4. Brugnara C. (2003) Iron deficiency and erythropoiesis: new diagnostic approaches. Clinical Chemistry 49, 1573-1578.
5. Brugnara C., Schiller B. & Moran J. (2006) Ret He and assessment of iron deficient states. Clinical and Laboratory Haematology 28, 303-308.
6. Brugnara C., Zelmanovic D., Sorette M., Ballas S.K. & Platt O. (1997) Reticulocyte Hemoglobin: an integrated parameter for evaluation of erythropoietic activity. American Journal of Clinical Pathology 108, 133-142.
7. Buttarello M., Temporin V., Ceravolo R., Farina G. & Burian P. (2004) The new reticulocyte parameter RET Y of the Sysmex XE 2100. Its use in the diagnosis and monitoring of post treatment sideropenic anemia. American Journal of Clinical Pathology 121, 489-495.
8. Canals C., Remacha A.F., Sarda M.P., Piazuelo J.M., Royo M.T. & Romero M.A. (2005) Clinical utility of the new Sysmex XE 2100 parameter reticulocyte hemoglobin equivalent in the diagnosis of anemia. Haematologica 90, 1133-1134.
9. David O., Grillo A., Ceoloni B., Cavallo F., Podda G., Biancotti P.P., Bergamo D. & Canavese C. (2006) Analysis of red cell parameters on the Sysmex XE 2100 and Advia 120 in iron deficiency and in uraemic chronic disease. Scandinavian Journal of Clinical and Laboratory Investigation 66, 113-120.
10. Fishbane S., Galgano C., Langley R.C., Jr, Canfield W. & Maesaka J.K. (1997) Reticulocyte hemoglobin content in the evaluation of iron status of hemodialysis patients. Kidney International 52, 217-222.
11. Garzia M., Di Mario A., Ferraro E., Tazza L., Rossi E., Luciani G. & Zini G. (2007) Reticulocyte Hemoglobin Equivalent: an indicator of reduced iron availability in chronic kidney diseases during erythropoietin therapy. Laboratory Haematology 13, 6-11.
12. Kazazin H. & Boehm C. (1988) Molecular basis and prenatal diagnosis of β thalassemia. Blood 72, 1170-1176.
13. Macdougall I.C., Cavill I., Hulme B., Bain B., Mcgregor E., Mckay P., Sanders E., Coles G.A. & Williams J.D. (1992) Detection of functional iron-deficiency during erythropoietin treatment - a new approach. British Medical Journal 304, 225-226.
14. Mast A.E., Blinder M.A. & Dietzen D.J. (2008) Reticulocyte haemoglobin content. American Journal of Hematology 83, 307-310.
15. Mast A.E., Blinder M.A., Lu Q., Flax S. & Dietzen D.J. (2002) Clinical utility of the reticulocyte hemoglobin content in the diagnosis of iron deficiency. Blood 99, 1489-1491.
16. National Kidney Foundation, Kidney Disease Outcomes Quality Initiative (NKF-K/DOQI) (2006) NKF-K/DOQI clinical practice guideline and clinical practice recommendations for anemia in chronic kidney disease. American Journal of Kidney Disease 47(Suppl 3), S11-S145.
17. Noronha J.F.A. & Grotto H.Z.W. (2005) Measurement of reticulocyte and red blood cell indices in patients with iron deficiency anemia and βthalassemia minor. Clinical Chemistry and Laboratory Medicine 43, 195-197.
18. d'Onofrio G., Chirillo R., Zini G., Caenaro G., Tommasi M. & Micciulli G. (1995) Simultaneous measurement of reticulocyte and red cell indices in healthy subjects and patients with microcytic and macrocytic anemia. Blood 85, 818-823.
19. Thein S.L. & Wallace R.S. (1986) The use of synthetic oligonucleotides as specific hybridation probes in the diagnosis of genetic disorders. In: Human genetic diseases, a practical approach (ed. KE Davis ), pp. 33-50. IRL press, Oxford-Washington DC.
20. Thomas L., Franck S., Messinger M., Linssen J., Thome M. & Thomas C. (2005) Reticulocyte hemoglobin measurement - comparison of two methods in the diagnosis of iron-restricted erythropoiesis. Clinical Chemistry and Laboratory Medicine 43, 1193-1202.
21. Thomas C., Kirschbaum A., Boehm D. & Thomas L. (2006) The diagnostic plot. Medical Oncology 23, 23-36.
22. Torres A., Sanchez J., Lakomsky D., Serrano J., Alvarez M.A., Martin C., Valls C., Nevado L., Rodriguez A., Casano J., Martinez F. & Gomez P. (2001) Assessment of hematologic progenitor engraftment by complete reticulocyte maturation parameters after autologous and allogeneic hematopoietic stem cell transplantation. Haematologica 86, 24-29.
23. Urrechaga E. (2009) Clinical utility of the new Beckman Coulter parameter red blood cell size factor in the study erythropoiesis. International Journal of Laboratory Hematology 31, 623-629.